NCT07363070Completed
Adherence to Chronic Positive Airway Pressure Therapy in Obese Patients With Sleep-disordered Breathing
Source: ClinicalTrials.gov · Last updated 23 Jan 2026
Brief summary (registry, in English)
To describe the adherence to positive airway pressure therapy among obese adult patients refered to the respiratory center east
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 300 (actual)
- First submitted
- 2 Jan 2026
- Start date
- 1 Jan 2021
- Primary completion date
- 1 Apr 2025
- Lead sponsor
- Anne Kathrine Staehr-Rye
- Diseases
- Obesity
- NCT number
- NCT07363070
What you commit to
- Study type: Observational
- Participants enrolled: 300
- From 1 Jan 2021 to the primary completion date, 1 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Already in treatment with nPAP with use of nPAP a minimum of 4 hours per night for 70% of the time within a consecutive 30-day period during the last 90 days.
Other illness
- Neuromuscular disease
Other
- Spinal cord injury
- Craniofacial malformation
- Scoliosis
- Diaphragmatic paresis
- Referred to profylactic secrete management only
- No medical indication for start of nPAP.
Who the study is looking for
- 18 years or older
- Body mass index above 30 kg/m2
- Referred to the Respiratory Center East between january 2021 and january 2024
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Respiratory Center East, Rigshospitalet Coordinator of this site? Confirm its status | Glostrup Municipality | Denmark | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.